Dr. Mastrodicasa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8333 Naab Rd
Ste 250
Indianapolis, IN 46260Phone+1 317-338-5100Fax+1 317-338-5101
Summary
- Dr. Mark Mastrodicasa is a pulmonologist based in Indianapolis, IN, with a subspecialty in critical care medicine. He completed his internal medicine residency and served as chief resident at The MetroHealth System/Case Western Reserve University, followed by a residency in pulmonary disease and critical care medicine at the University of Cincinnati Medical Center. He graduated from St. George's University School of Medicine in 2009. Dr. Mastrodicasa has experience with asthma and has published a review on long-acting muscarinic antagonists for chronic obstructive pulmonary disease, which has been cited 12 times.
Education & Training
- University of Cincinnati Medical Center/College of MedicineResidency, Pulmonary Disease and Critical Care Medicine, 2017
- The MetroHealth System/Case Western Reserve UniversityChief Residency, Internal Medicine, 2013 - 2014
- The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 2010 - 2013
- St. George's University School of MedicineClass of 2009
Certifications & Licensure
- IN State Medical License 2017 - 2025
- OH State Medical License 2010 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 12 citationsLong acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugsMark A Mastrodicasa, Christopher A. Droege, Aaron M. Mulhall, Neil Ernst, Ralph J. Panos
Expert Opinion on Investigational Drugs. 2017-01-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: